All treatment decisions are made in consultation with a qualified healthcare provider, and individual results may vary
The information is not intended to diagnose, treat, cure, or prevent any disease or health condition
Because they do not pass through your digestive system, theyre not affected by GLP-1s
Ultimately, the goal is to improve the quality of life for patients, offering them not just longer lives but fuller and healthier ones
It has received fast-track designation from the FDA and was granted priority medicine (PRIME) status by the European Medicines Agency (EMA) in November of last year for the treatment of MASH with fibrosis
Researchers say patients should not have to choose between affordability and quality and call for greater transparency and oversight while preserving access